Navigation Links
HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
Date:8/12/2011

FRAMINGHAM, Mass and SYDNEY, Aug. 12, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the Wedbush Securities 2011 Life Sciences Management Access Conference at 9:10 a.m. Eastern Time on Wednesday, August 17, 2011.  The conference is being held August 16-17, 2011 at Le Parker Meridien in New York City.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  An archived replay of the presentation will also be available shortly after the presentation time for 90 days.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union and TGA approval in Australia.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare to Present at the Canaccord Genuity 31st Annual Growth Conference
2. HeartWare International Reports Second Quarter 2011 Revenues of $20.4 Million; 109% Increase From $9.8 Million in Second Quarter 2010
3. HeartWare to Report Financial Results for Second Quarter of 2011
4. HeartWare to Present at the Wells Fargo 2011 Healthcare Conference
5. HeartWare to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
6. HeartWare International Reports First Quarter 2011 Revenues of $18.0 Million; 68% Increase From $10.7 Million in First Quarter 2010
7. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
8. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
9. HeartWare International Receives Approval From the Therapeutic Goods Administration (TGA) in Australia
10. HeartWare to Present at the Barclays Capital 2011 Global Healthcare Conference
11. HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and financial setbacks, a senior finds a new lease on life with assistance ... thousands of people resolve their problem with unsecured debt. The senior is one ...
(Date:9/22/2017)... ... ... “Cursed with a Curse: The Truth about Tithing”: a ... when breaking free from this misconception. “Cursed with a Curse: The Truth about ... Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and thought-provoking ...
(Date:9/22/2017)... ... ... of the Spirit: “Love””: a delightful adventure of two friends who play and ... “Love”” is the creation of published author, Halimah Jones, who was born and raised ... avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from her background ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... With ... so fun and easy to do. Users can select from up to two layers ... with a click of a mouse all within Final Cut Pro X. ...
(Date:9/21/2017)... ... 21, 2017 , ... Promotional Communication:, Keeping Up with FDA’s ... the competitive world of drug and device marketing and promotion, drug and devicemakers ... , The FDA has issued two draft guidances that are the closest thing ...
Breaking Medicine News(10 mins):